249 related articles for article (PubMed ID: 31830575)
1. Mucoadhesive dexamethasone-glycol chitosan nanoparticles for ophthalmic drug delivery.
Yu A; Shi H; Liu H; Bao Z; Dai M; Lin D; Lin D; Xu X; Li X; Wang Y
Int J Pharm; 2020 Feb; 575():118943. PubMed ID: 31830575
[TBL] [Abstract][Full Text] [Related]
2. Supramolecular nanofibers of dexamethasone derivatives to form hydrogel for topical ocular drug delivery.
Zhang Z; Yu J; Zhou Y; Zhang R; Song Q; Lei L; Li X
Colloids Surf B Biointerfaces; 2018 Apr; 164():436-443. PubMed ID: 29438842
[TBL] [Abstract][Full Text] [Related]
3. High drug payload nanoparticles formed from dexamethasone-peptide conjugates for the treatment of endotoxin-induced uveitis in rabbit.
Yu X; Zhang R; Lei L; Song Q; Li X
Int J Nanomedicine; 2019; 14():591-603. PubMed ID: 30666116
[TBL] [Abstract][Full Text] [Related]
4. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():559-68. PubMed ID: 27164496
[TBL] [Abstract][Full Text] [Related]
5. Functional chitosan oligosaccharide nanomicelles for topical ocular drug delivery of dexamethasone.
Xu X; Sun L; Zhou L; Cheng Y; Cao F
Carbohydr Polym; 2020 Jan; 227():115356. PubMed ID: 31590850
[TBL] [Abstract][Full Text] [Related]
6. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
Amin MK; Boateng JS
Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
[No Abstract] [Full Text] [Related]
7. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Characterization of Novel Succinyl Chitosan-Dexamethasone Conjugates for Potential Intravitreal Dexamethasone Delivery.
Dubashynskaya NV; Bokatyi AN; Golovkin AS; Kudryavtsev IV; Serebryakova MK; Trulioff AS; Dubrovskii YA; Skorik YA
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681619
[TBL] [Abstract][Full Text] [Related]
9. Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface.
Chaiyasan W; Srinivas SP; Tiyaboonchai W
J Ocul Pharmacol Ther; 2013 Mar; 29(2):200-7. PubMed ID: 23356788
[TBL] [Abstract][Full Text] [Related]
10. Cation instructed steroidal prodrug supramolecular hydrogel.
Zhou Y; Lei L; Zhang Z; Zhang R; Song Q; Li X
J Colloid Interface Sci; 2018 Oct; 528():10-17. PubMed ID: 29803956
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
[TBL] [Abstract][Full Text] [Related]
12. Silk fibroin hydrogel/dexamethasone sodium phosphate loaded chitosan nanoparticles as a potential drug delivery system.
Akrami-Hasan-Kohal M; Eskandari M; Solouk A
Colloids Surf B Biointerfaces; 2021 Sep; 205():111892. PubMed ID: 34107443
[TBL] [Abstract][Full Text] [Related]
13. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
14. Thermosensitive glycol chitosan-based hydrogel as a topical ocular drug delivery system for enhanced ocular bioavailability.
Shi H; Wang Y; Bao Z; Lin D; Liu H; Yu A; Lei L; Li X; Xu X
Int J Pharm; 2019 Oct; 570():118688. PubMed ID: 31513870
[TBL] [Abstract][Full Text] [Related]
15. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation.
Kesavan K; Kant S; Singh PN; Pandit JK
Curr Eye Res; 2013 Mar; 38(3):342-52. PubMed ID: 23216079
[TBL] [Abstract][Full Text] [Related]
16. Glycol chitosan/oxidized hyaluronic acid hydrogel film for topical ocular delivery of dexamethasone and levofloxacin.
Bao Z; Yu A; Shi H; Hu Y; Jin B; Lin D; Dai M; Lei L; Li X; Wang Y
Int J Biol Macromol; 2021 Jan; 167():659-666. PubMed ID: 33278439
[TBL] [Abstract][Full Text] [Related]
17. Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study.
Nagarwal RC; Singh PN; Kant S; Maiti P; Pandit JK
Chem Pharm Bull (Tokyo); 2011; 59(2):272-8. PubMed ID: 21297311
[TBL] [Abstract][Full Text] [Related]
18. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone.
Wen Y; Ban J; Mo Z; Zhang Y; An P; Liu L; Xie Q; Du Y; Xie B; Zhan X; Tan L; Chen Y; Lu Z
Nanotechnology; 2018 Oct; 29(42):425101. PubMed ID: 30074486
[TBL] [Abstract][Full Text] [Related]
19. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
Deng F; Hu W; Chen H; Tang Y; Zhang L
Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869
[TBL] [Abstract][Full Text] [Related]
20. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome.
Tan G; Li J; Song Y; Yu Y; Liu D; Pan W
Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
